Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

May 01, 2017; Volume 45,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Almon, Richard R.

    1. You have access
      Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 476-483; DOI: https://doi.org/10.1124/dmd.116.074500
    2. You have access
      Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 484-491; DOI: https://doi.org/10.1124/dmd.116.074526
  2. Argikar, Upendra A.

    1. You have access
      Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic Standards
      Panos Hatsis, Nigel J. Waters and Upendra A. Argikar
      Drug Metabolism and Disposition May 2017, 45 (5) 492-496; DOI: https://doi.org/10.1124/dmd.117.075259
  3. Atkinson, Karen

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575

B

  1. Billington, Sarah

    1. Open Access
      Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
      Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan and Aleksandra Galetin
      Drug Metabolism and Disposition May 2017, 45 (5) 556-568; DOI: https://doi.org/10.1124/dmd.117.075242
  2. Brown, Colin D. A.

    1. Open Access
      Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
      Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan and Aleksandra Galetin
      Drug Metabolism and Disposition May 2017, 45 (5) 556-568; DOI: https://doi.org/10.1124/dmd.117.075242
  3. Brown, Jay

    1. Open Access
      Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
      Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan and Aleksandra Galetin
      Drug Metabolism and Disposition May 2017, 45 (5) 556-568; DOI: https://doi.org/10.1124/dmd.117.075242
  4. Buckbinder, Leonard

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476

C

  1. Camenisch, Gian

    1. You have access
      Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations
      Julia Riede, Birk Poller, Jörg Huwyler and Gian Camenisch
      Drug Metabolism and Disposition May 2017, 45 (5) 523-531; DOI: https://doi.org/10.1124/dmd.116.074179
  2. Chabot, Jeffrey R.

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  3. Chen, Qingfang

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  4. Chen, Xiaoyan

    1. You have access
      Nimesulide and 4′-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis
      Lei Zhou, Xiaoyan Pang, Jingfang Jiang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition May 2017, 45 (5) 441-448; DOI: https://doi.org/10.1124/dmd.116.074104
  5. Chen, Yuan

    1. You have access
      Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450
      Ryan H. Takahashi, Jason S. Halladay, Michael Siu, Yuan Chen, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Shuguang Ma
      Drug Metabolism and Disposition May 2017, 45 (5) 430-440; DOI: https://doi.org/10.1124/dmd.116.074336
  6. Chidsey, Kristin

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  7. Clewell, Harvey J.

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583
  8. Creek, Moire R.

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583

D

  1. Di, Li

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575
  2. Dong, Jennifer Q.

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  3. Dong, Kelly

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  4. DuBois, Debra C.

    1. You have access
      Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 476-483; DOI: https://doi.org/10.1124/dmd.116.074500
    2. You have access
      Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 484-491; DOI: https://doi.org/10.1124/dmd.116.074526

F

  1. Fahmi, Odette A.

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  2. Fu, Tingting

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245

G

  1. Galetin, Aleksandra

    1. Open Access
      Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
      Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan and Aleksandra Galetin
      Drug Metabolism and Disposition May 2017, 45 (5) 556-568; DOI: https://doi.org/10.1124/dmd.117.075242
  2. Gao, Ruina

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  3. Gatlik, Ewa

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  4. Gerber, Jacobus P.

    1. You have access
      Effect of Garlic, Gingko, and St. John’s Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study
      Jasmina Turkanovic, Michael B. Ward, Jacobus P. Gerber and Robert W. Milne
      Drug Metabolism and Disposition May 2017, 45 (5) 569-575; DOI: https://doi.org/10.1124/dmd.116.073528
  5. Gosset, James R.

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  6. Gu, Helen

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744

H

  1. Halladay, Jason S.

    1. You have access
      Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450
      Ryan H. Takahashi, Jason S. Halladay, Michael Siu, Yuan Chen, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Shuguang Ma
      Drug Metabolism and Disposition May 2017, 45 (5) 430-440; DOI: https://doi.org/10.1124/dmd.116.074336
  2. Hatsis, Panos

    1. You have access
      Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic Standards
      Panos Hatsis, Nigel J. Waters and Upendra A. Argikar
      Drug Metabolism and Disposition May 2017, 45 (5) 492-496; DOI: https://doi.org/10.1124/dmd.117.075259
  3. He, Handan

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  4. Heimbach, Tycho

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  5. Hines, Ronald N.

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583
  6. Hop, Cornelis E. C. A.

    1. You have access
      Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450
      Ryan H. Takahashi, Jason S. Halladay, Michael Siu, Yuan Chen, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Shuguang Ma
      Drug Metabolism and Disposition May 2017, 45 (5) 430-440; DOI: https://doi.org/10.1124/dmd.116.074336
  7. Hua, Wenyi

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575
  8. Huang, Liang

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  9. Huwyler, Jörg

    1. You have access
      Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations
      Julia Riede, Birk Poller, Jörg Huwyler and Gian Camenisch
      Drug Metabolism and Disposition May 2017, 45 (5) 523-531; DOI: https://doi.org/10.1124/dmd.116.074179

I

  1. Inoue, Takashi

    1. You have access
      Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone
      Shotaro Uehara, Yasuhiro Uno, Kazuyuki Nakanishi, Sakura Ishii, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 457-467; DOI: https://doi.org/10.1124/dmd.116.074898
    2. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      You have access
      Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      Shotaro Uehara, Makiko Shimizu, Yasuhiro Uno, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 497-500; DOI: https://doi.org/10.1124/dmd.117.075184
  2. Ishii, Sakura

    1. You have access
      Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone
      Shotaro Uehara, Yasuhiro Uno, Kazuyuki Nakanishi, Sakura Ishii, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 457-467; DOI: https://doi.org/10.1124/dmd.116.074898

J

  1. Jiang, Jingfang

    1. You have access
      Nimesulide and 4′-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis
      Lei Zhou, Xiaoyan Pang, Jingfang Jiang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition May 2017, 45 (5) 441-448; DOI: https://doi.org/10.1124/dmd.116.074104
  2. Jilek, Joseph L.

    1. You have access
      Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice
      Joseph L. Jilek, Ye Tian and Ai-Ming Yu
      Drug Metabolism and Disposition May 2017, 45 (5) 512-522; DOI: https://doi.org/10.1124/dmd.116.074344
  3. Jones, Christopher R.

    1. Open Access
      Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
      Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan and Aleksandra Galetin
      Drug Metabolism and Disposition May 2017, 45 (5) 556-568; DOI: https://doi.org/10.1124/dmd.117.075242
  4. Jusko, William J.

    1. You have access
      Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 476-483; DOI: https://doi.org/10.1124/dmd.116.074500
    2. You have access
      Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 484-491; DOI: https://doi.org/10.1124/dmd.116.074526

K

  1. Kalgutkar, Amit S.

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  2. Khojasteh, S. Cyrus

    1. You have access
      Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450
      Ryan H. Takahashi, Jason S. Halladay, Michael Siu, Yuan Chen, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Shuguang Ma
      Drug Metabolism and Disposition May 2017, 45 (5) 430-440; DOI: https://doi.org/10.1124/dmd.116.074336
  3. Kim, Albert

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  4. Klein, Kai

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  5. Kosa, Rachel E.

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575

L

  1. Lake, Brian G.

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583
  2. Le, Vu

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  3. Li, Xiaonan

    1. You have access
      Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 476-483; DOI: https://doi.org/10.1124/dmd.116.074500
    2. You have access
      Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis
      Xiaonan Li, Debra C. DuBois, Richard R. Almon and William J. Jusko
      Drug Metabolism and Disposition May 2017, 45 (5) 484-491; DOI: https://doi.org/10.1124/dmd.116.074526
  4. Li, Yi

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  5. Li, Zhenhong

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575
  6. Lin, Jian

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575
  7. Lin, Wen

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  8. Lin, Zhiwu

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  9. Litchfield, John

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575
  10. Liu, Houfu

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245

M

  1. Ma, Shuguang

    1. You have access
      Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450
      Ryan H. Takahashi, Jason S. Halladay, Michael Siu, Yuan Chen, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Shuguang Ma
      Drug Metabolism and Disposition May 2017, 45 (5) 430-440; DOI: https://doi.org/10.1124/dmd.116.074336
  2. McCarver, D. Gail

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583
  3. Milne, Robert W.

    1. You have access
      Effect of Garlic, Gingko, and St. John’s Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study
      Jasmina Turkanovic, Michael B. Ward, Jacobus P. Gerber and Robert W. Milne
      Drug Metabolism and Disposition May 2017, 45 (5) 569-575; DOI: https://doi.org/10.1124/dmd.116.073528

N

  1. Nakanishi, Kazuyuki

    1. You have access
      Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone
      Shotaro Uehara, Yasuhiro Uno, Kazuyuki Nakanishi, Sakura Ishii, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 457-467; DOI: https://doi.org/10.1124/dmd.116.074898
  2. Negishi, Masahiko

    1. You have access
      Phenobarbital Meets Phosphorylation of Nuclear Receptors
      Masahiko Negishi
      Drug Metabolism and Disposition May 2017, 45 (5) 532-539; DOI: https://doi.org/10.1124/dmd.116.074872
  3. Niosi, Mark

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575
  4. Nouri, Parya

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476

O

  1. Osimitz, Thomas G.

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583

P

  1. Pang, Xiaoyan

    1. You have access
      Nimesulide and 4′-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis
      Lei Zhou, Xiaoyan Pang, Jingfang Jiang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition May 2017, 45 (5) 441-448; DOI: https://doi.org/10.1124/dmd.116.074104
  2. Poller, Birk

    1. You have access
      Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations
      Julia Riede, Birk Poller, Jörg Huwyler and Gian Camenisch
      Drug Metabolism and Disposition May 2017, 45 (5) 523-531; DOI: https://doi.org/10.1124/dmd.116.074179

R

  1. Riccardi, Keith

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575
  2. Riede, Julia

    1. You have access
      Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations
      Julia Riede, Birk Poller, Jörg Huwyler and Gian Camenisch
      Drug Metabolism and Disposition May 2017, 45 (5) 523-531; DOI: https://doi.org/10.1124/dmd.116.074179
  3. Rostami-Hodjegan, Amin

    1. Open Access
      Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
      Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan and Aleksandra Galetin
      Drug Metabolism and Disposition May 2017, 45 (5) 556-568; DOI: https://doi.org/10.1124/dmd.117.075242
  4. Ryu, Sangwoo

    1. You have access
      Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
      Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield and Li Di
      Drug Metabolism and Disposition May 2017, 45 (5) 576-580; DOI: https://doi.org/10.1124/dmd.116.074575

S

  1. Sahi, Jasminder

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  2. Sasaki, Erika

    1. You have access
      Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone
      Shotaro Uehara, Yasuhiro Uno, Kazuyuki Nakanishi, Sakura Ishii, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 457-467; DOI: https://doi.org/10.1124/dmd.116.074898
    2. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      You have access
      Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      Shotaro Uehara, Makiko Shimizu, Yasuhiro Uno, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 497-500; DOI: https://doi.org/10.1124/dmd.117.075184
  3. Scotcher, Daniel

    1. Open Access
      Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
      Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan and Aleksandra Galetin
      Drug Metabolism and Disposition May 2017, 45 (5) 556-568; DOI: https://doi.org/10.1124/dmd.117.075242
  4. Shimizu, Makiko

    1. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      You have access
      Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      Shotaro Uehara, Makiko Shimizu, Yasuhiro Uno, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 497-500; DOI: https://doi.org/10.1124/dmd.117.075184
  5. Siu, Michael

    1. You have access
      Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450
      Ryan H. Takahashi, Jason S. Halladay, Michael Siu, Yuan Chen, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Shuguang Ma
      Drug Metabolism and Disposition May 2017, 45 (5) 430-440; DOI: https://doi.org/10.1124/dmd.116.074336
  6. Song, Gina

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583
  7. Summerfield, Scott

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  8. Sun, Xueying

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583
    2. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245

T

  1. Takahashi, Ryan H.

    1. You have access
      Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450
      Ryan H. Takahashi, Jason S. Halladay, Michael Siu, Yuan Chen, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Shuguang Ma
      Drug Metabolism and Disposition May 2017, 45 (5) 430-440; DOI: https://doi.org/10.1124/dmd.116.074336
  2. Tedesco, Vivienne

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  3. Terra, Steven G.

    1. You have access
      Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome
      Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder and Amit S. Kalgutkar
      Drug Metabolism and Disposition May 2017, 45 (5) 501-511; DOI: https://doi.org/10.1124/dmd.116.074476
  4. Tian, Ye

    1. You have access
      Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice
      Joseph L. Jilek, Ye Tian and Ai-Ming Yu
      Drug Metabolism and Disposition May 2017, 45 (5) 512-522; DOI: https://doi.org/10.1124/dmd.116.074344
  5. Tran, Phi

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  6. Turkanovic, Jasmina

    1. You have access
      Effect of Garlic, Gingko, and St. John’s Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study
      Jasmina Turkanovic, Michael B. Ward, Jacobus P. Gerber and Robert W. Milne
      Drug Metabolism and Disposition May 2017, 45 (5) 569-575; DOI: https://doi.org/10.1124/dmd.116.073528

U

  1. Uehara, Shotaro

    1. You have access
      Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone
      Shotaro Uehara, Yasuhiro Uno, Kazuyuki Nakanishi, Sakura Ishii, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 457-467; DOI: https://doi.org/10.1124/dmd.116.074898
    2. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      You have access
      Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      Shotaro Uehara, Makiko Shimizu, Yasuhiro Uno, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 497-500; DOI: https://doi.org/10.1124/dmd.117.075184
  2. Uno, Yasuhiro

    1. You have access
      Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone
      Shotaro Uehara, Yasuhiro Uno, Kazuyuki Nakanishi, Sakura Ishii, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 457-467; DOI: https://doi.org/10.1124/dmd.116.074898
    2. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      You have access
      Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      Shotaro Uehara, Makiko Shimizu, Yasuhiro Uno, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 497-500; DOI: https://doi.org/10.1124/dmd.117.075184

W

  1. Ward, Michael B.

    1. You have access
      Effect of Garlic, Gingko, and St. John’s Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study
      Jasmina Turkanovic, Michael B. Ward, Jacobus P. Gerber and Robert W. Milne
      Drug Metabolism and Disposition May 2017, 45 (5) 569-575; DOI: https://doi.org/10.1124/dmd.116.073528
  2. Waters, Nigel J.

    1. You have access
      Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic Standards
      Panos Hatsis, Nigel J. Waters and Upendra A. Argikar
      Drug Metabolism and Disposition May 2017, 45 (5) 492-496; DOI: https://doi.org/10.1124/dmd.117.075259

Y

  1. Yamazaki, Hiroshi

    1. You have access
      Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone
      Shotaro Uehara, Yasuhiro Uno, Kazuyuki Nakanishi, Sakura Ishii, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 457-467; DOI: https://doi.org/10.1124/dmd.116.074898
    2. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      You have access
      Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase
      Shotaro Uehara, Makiko Shimizu, Yasuhiro Uno, Takashi Inoue, Erika Sasaki and Hiroshi Yamazaki
      Drug Metabolism and Disposition May 2017, 45 (5) 497-500; DOI: https://doi.org/10.1124/dmd.117.075184
  2. Yoon, Miyoung

    1. You have access
      Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
      Gina Song, Xueying Sun, Ronald N. Hines, D. Gail McCarver, Brian G. Lake, Thomas G. Osimitz, Moire R. Creek, Harvey J. Clewell and Miyoung Yoon
      Drug Metabolism and Disposition May 2017, 45 (5) 468-475; DOI: https://doi.org/10.1124/dmd.116.074583
  3. Yu, Ai-Ming

    1. You have access
      Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice
      Joseph L. Jilek, Ye Tian and Ai-Ming Yu
      Drug Metabolism and Disposition May 2017, 45 (5) 512-522; DOI: https://doi.org/10.1124/dmd.116.074344

Z

  1. Zhang, Jin

    1. You have access
      Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug
      Handan He, Phi Tran, Helen Gu, Vivienne Tedesco, Jin Zhang, Wen Lin, Ewa Gatlik, Kai Klein and Tycho Heimbach
      Drug Metabolism and Disposition May 2017, 45 (5) 540-555; DOI: https://doi.org/10.1124/dmd.116.072744
  2. Zhang, Wandong

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  3. Zhang, Yan-Yan

    1. You have access
      Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein
      Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield and Kelly Dong
      Drug Metabolism and Disposition May 2017, 45 (5) 449-456; DOI: https://doi.org/10.1124/dmd.116.074245
  4. Zhong, Dafang

    1. You have access
      Nimesulide and 4′-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis
      Lei Zhou, Xiaoyan Pang, Jingfang Jiang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition May 2017, 45 (5) 441-448; DOI: https://doi.org/10.1124/dmd.116.074104
  5. Zhou, Lei

    1. You have access
      Nimesulide and 4′-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis
      Lei Zhou, Xiaoyan Pang, Jingfang Jiang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition May 2017, 45 (5) 441-448; DOI: https://doi.org/10.1124/dmd.116.074104
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 45 (5)
Drug Metabolism and Disposition
Vol. 45, Issue 5
1 May 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics